KCNQ2 Cure Alliance (EIN 471810644) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

Scotty Sims

Phone

3038879532

Tax Period

2024-01-01 to 2024-12-31

KCNQ2 Cure Alliance, founded in 2015, is a small nonprofit in the Diseases & Disorders sector that reported $458K in total revenue in fiscal year 2024. Revenue surged 53% from the prior year, signaling strong growth momentum. The organization ran a surplus of $372K, a strong 81% operating margin.

Mission

KCNQ2 Cure Alliance is a non-profit organization dedicated to raising research funds for KCNQ2 epileptic encephalopathy, a rare and catastrophic form of epilepsy. By offering research grants for KCNQ2 research with a novel approach, we can move researchers and the medical community forward to find better treatments and a cure while assisting afflicted individuals and their families.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $387,797

Program Service Revenue $0

Investment Income $70,678

Other Revenue $0

TOTAL REVENUE $458,475

Expense Breakdown

Grants Paid $15,117

Salaries & Benefits $0

Fundraising Expenses $6,773

Program Expenses $55,398

Other Expenses $71,117

TOTAL EXPENSES $86,234

Year-over-Year Comparison

	2024	2023	Change
Revenue	$458,475	$298,727	+0.5%
Expenses	$86,234	$134,391	-0.4%
Net Income	$372,241	$164,336	+1.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jim Johnson	President	5.00	Officer Director	$0	$0	$0
Sara James	Vice President	5.00	Officer Director	$0	$0	$0
Caroline Loewy	Treasurer	5.00	Officer Director	$0	$0	$0
Matthew Fox	Director	0.00	Director	$0	$0	$0
Colin Sanford	Secretary	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$458,475	$86,234	$1,234,962	$372,241
2023	$298,727	$134,391	$881,712	$164,336
2022	$172,403	$43,702	$730,127	$128,701
2021	$185,161	$118,531	$601,426	$66,630
2020	$177,690	$16,581	$534,796	$161,109

KCNQ2 Cure Alliance